Company Fermentalg

Equities

ALGAE

FR0011271600

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for Fermentalg

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 16:37:26 26/04/2024 BST			5-day change	1st Jan Change
0.565 ^EUR	-0.18%		-5.52%	+87.09%

04-12	Fermentalg: transfer to Euronext Growth on April 16	CF
04-04	Fermentalg SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Fermentalg is an expert in the research and bio-industrial exploitation of micro-algae and aims to provide sustainable solutions and innovative products that contribute to the development of healthy, natural and high-performance products. Its business: the development, production and marketing of sustainable solutions and active ingredients derived from microalgae for nutrition, health and the environment. Nutritional lipids, alternative proteins and natural food colorants make up the company's current and future offer.

Number of employees: 57

EUR in Million	2021	Weight	2022	Weight	Delta
Fermentation Microalgae 99.5 %	6	99.6 %	8	99.5 %	+35.28%
Charges and Admission 0.5 %	0	0.4 %	0	0.5 %	+73.91%

EUR in Million	2021	Weight	2022	Weight	Delta
France 100.0 %	6	100.0 %	8	100.0 %	+35.43%

Managers	Title	Age	Since
Pierre Josselin CEO	Chief Executive Officer	-	03/05/23
Bertrand Devillers DFI	Director of Finance/CFO	-	-
Philippe Lavielle CHM	Chairman	-	-
Hywel Griffiths CTO	Chief Tech/Sci/R&D Officer	-	01/09/14
Alfonso Moreda SAM	Sales & Marketing	-	-
Sonia Da Rocha Gomes PRN	Corporate Officer/Principal	-	-
Emmanuelle Toury HRO	Human Resources Officer	-	-
Véronique Roumegous LAW	General Counsel	-	-

Members of the board	Title	Age	Since
Gilles Schang BRD	Director/Board Member	-	-
Philippe Lavielle CHM	Chairman	-	-
Stéphane Villecroze BRD	Director/Board Member	56	-
Vanessa Giraud BRD	Director/Board Member	50	-
Fabienne Saadane-Oaks BRD	Director/Board Member	66	-
Audrey Ménassé BRD	Director/Board Member	-	-
Hélène Moncorger-Pilicer BRD	Director/Board Member	-	18/06/19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	42,858,271	40,766,030 ( 95.12 %)	95,728 ( 0.2234 %)	95.12 %

Name	Equities	%	Valuation
BPIFrance Investissement SAS 7.411 %	3,060,156	7.411 %	2 M €
Bpifrance Participations SA /PRIVATE EQUITY/ 7.226 %	2,983,810	7.226 %	2 M €
Moneta Asset Management SAS 5.792 %	2,391,480	5.792 %	2 M €
Demeter Ventures SA 5.514 %	2,276,754	5.514 %	2 M €
Theodore Nixon 4.403 %	1,818,181	4.403 %	1 M €
OFI Invest Asset Management SA 0.9687 %	400,000	0.9687 %	297 216 €
DNCA Finance SA 0.7622 %	314,728	0.7622 %	233 855 €
FPM Frankfurt Performance Management AG 0.4117 %	170,000	0.4117 %	126 317 €
Chaussier Gestion SA 0.1695 %	70,000	0.1695 %	52 013 €
Gestys SA 0.0848 %	35,000	0.0848 %	26 006 €

Fermentalg SA

4, rue Riviere

33500, Libourne

+33 5 57 25 02 20

http://www.fermentalg.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.565 EUR

Average target price

0.5 EUR

Spread / Average Target

-11.50%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
FERMENTALG	+87.09%	24.85M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research